Evaluation of risk factors for the development of cirrhosis in autoimmune hepatitis: Japanese NHO-AIH prospective study

Journal of Gastroenterology

Volumn 46, Issue SUPPL. 1, 2011, Pages 56-62

  Migita, Kiyoshi ^a   Watanabe, Yukio ^a   Jiuchi, Yuka ^a   Nakamura, Yoko ^a   Saito, Akira ^a   Yagura, Michiyasu ^a   Morimoto, Hideo ^a   Shimada, Masaaki ^a   Mita, Eiji ^a   Hijioka, Taizo ^a   Yamashita, Haruhiro ^a   Takezaki, Eiichi ^a   Muro, Toyokichi ^a   Sakai, Hironori ^a   Nakamuta, Makoto ^a   Abiru, Seigo ^a   Yano, Koji ^a   Komori, Atsumasa ^a   Yatsuhashi, Hiroshi ^a   Nakamura, Minoru ^a   Ishibashi, Hiromi ^a   more..

^a NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

Author keywords

Autoimmune hepatitis; Liver cirrhosis; Multicenter cohort study; Outcome

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CORTICOSTEROID;

ACUTE HEPATITIS; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; CHRONIC HEPATITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPATHOGENESIS; JAPANESE; LIVER CIRRHOSIS; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STEROID THERAPY; SURVIVAL; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; AUTOANTIBODIES; COHORT STUDIES; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HEPATITIS, AUTOIMMUNE; HUMANS; JAPAN; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLATELET COUNT; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL; YOUNG ADULT;

EID: 78651377234     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-010-0337-y     Document Type: Article

References (20)

1. EL Krawitt 1996 Autoimmune hepatitis N Engl J Med 334 897 903 1:STN:280:DyaK287nsFygsg%3D%3D 10.1056/NEJM199604043341406 8596574 (Pubitemid 26107349)
2. PT Donaldson AJ Czaja 2002 Genetic effects on susceptibility, clinical expression, and treatment outcome of type 1 autoimmune hepatitis Clin Liver Dis 6 707 725 10.1016/S1089-3261(02)00023-5 12362576
3. EL Krawitt 2008 Clinical features and management of autoimmune hepatitis World J Gastroenterol 14 3301 3305 1:CAS:528:DC%2BD1cXhtFylt7%2FJ 10.3748/wjg.14.3301 18528927
4. JF Dufour R DeLellis MM Kaplan 1997 Reversibility of hepatic fibrosis in autoimmune hepatitis Ann Intern Med 127 981 985 1:STN:280:DyaK1c%2FjtF2ltQ%3D%3D 9412303
5. Y Miyake Y Iwasaki R Terada S Takagi R Okamaoto H Ikeda, et al. 2005 Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis J Hepatol 43 951 957 1:CAS:528:DC%2BD2MXht1egsrnJ 10.1016/j.jhep.2005.06.006 16143423 (Pubitemid 41627979)
6. F Alvarez PA Berg FB Bianchi L Bianchi AK Burroughs EL Cancado, et al. 1999 International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis J Hepatol 31 929 938 1:STN:280: DC%2BD3c%2Fks1Ggug%3D%3D 10.1016/S0168-8278(99)80297-9 10580593 (Pubitemid 29514229)
7. VJ Desmet M Gerber JH Hoofnagle M Manns PJ Scheuer 1994 Classification of chronic hepatitis: diagnosis, grading and staging Hepatology 19 1513 1520 1:STN:280:DyaK2c3ksFWisw%3D%3D 10.1002/hep.1840190629 8188183
8. S Yatsuji E Hashimoto H Kaneda M Taniai K Tokushige K Shiratori 2005 Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful? J Gastroenterol 40 1130 1138 10.1007/s00535-005-1711-z 16378177 (Pubitemid 43124840)
9. M Zeniya F Watanabe T Morizane M Shibata S Maeyama M Kage Study Group of Intractable Liver Diseases for Research on a Specific Disease, Health Science Research Grant, Ministry of Health, Labour, and Welfare of Japan, et al. 2005 Diagnosing clinical subsets of autoimmune liver diseases based on a multivariable model J Gastroenterol 40 1148 1154 10.1007/s00535-005-1713-x 16378179 (Pubitemid 43124842)
10. MP Manns AJ Czaja JD Gorham EL Krawitt G Mieli-Vergani D Vergani American Association for the Study of Liver Diseases, et al. 2010 Diagnosis and management of autoimmune hepatitis Hepatology 51 2193 2213 1:CAS:528: DC%2BC3cXnslyqtbc%3D 20513004
11. Y Ichiki CA Aoki CL Bowlus S Shimoda H Ishibashi ME Gershwin 2005 T cell immunity in autoimmune hepatitis Autoimmun Rev 4 315 321 1:CAS:528: DC%2BD2MXpsFGlsLk%3D 10.1016/j.autrev.2005.01.005 15990080 (Pubitemid 40884551)
12. B Eksteen SC Afford SJ Wigmore AP Holt DH Adams 2007 Immune-mediated liver injury Semin Liver Dis 27 351 366 1:CAS:528:DC%2BD2sXhtl2gsrrK 10.1055/s-2007-991512 17979072 (Pubitemid 350071836)
13. M Durazzo G Niro A Premoli E Morello ER Rizzotto R Gambino, et al. 2009 Type 1 autoimmune hepatitis and adipokines: new markers for activity and disease progression? J Gastroenterol 44 476 482 1:CAS:528:DC%2BD1MXlslCrsbw%3D 10.1007/s00535-009-0023-0 19301087
14. AJ Czaja HA Carpenter 2006 Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly Hepatology 43 532 538 10.1002/hep.21074 16496338
15. SL Friedman 2004 Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications Nat Clin Pract Gastroenterol Hepatol 1 98 105 10.1038/ncpgasthep0055 16265071 (Pubitemid 40823677)
16. AP Holt M Salmon CD Buckley DH Adams 2008 Immune interactions in hepatic fibrosis Clin Liver Dis 12 861 882 10.1016/j.cld.2008.07.002 18984471
17. T Miyake H Miyaoka M Abe S Furukawa S Shigematsu E Furukawa, et al. 2006 Clinical characteristics of autoimmune hepatitis in older aged patients Hepatol Res 36 139 142 10.1016/j.hepres.2006.06.007 16872893 (Pubitemid 44480644)
18. D Vergani MS Longhi DP Bogdanos Y Ma G Mieli-Vergani 2009 Autoimmune hepatitis Semin Immunopathol 31 421 435 1:CAS:528:DC%2BD1MXhtFOrsLbP 10.1007/s00281-009-0170-7 19533129
19. EJ Kovacs JL Palmer CF Fortin T Fülöp Jr DR Goldstein PJ Linton 2009 Aging and innate immunity in the mouse: impact of intrinsic and extrinsic factors Trends Immunol 30 319 324 1:CAS:528:DC%2BD1MXotF2gtrg%3D 10.1016/j.it.2009.03.012 19541536
20. D Goukassian F Gad M Yaar MS Eller US Nehal BA Gilchrest 2000 Mechanisms and implications of the age-associated decrease in DNA repair capacity FASEB J 14 1325 1334 1:CAS:528:DC%2BD3cXks12jtLc%3D 10.1096/fj.14.10.1325 10877825